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Abstract
Background Radiofrequency (RF) catheter ablation for
atrioventricular nodal reentrant tachycardia (AVNRT) is
highly successful but carries a risk for inadvertent atrio-
ventricular block. Cryoablation (cryo) has the potential to
assess the safety of a site before the energy is applied.
Purpose The aim of this study was to evaluate the long-
term efficacy and safety of cryothermal ablation in a large
series of patients and compare it to RF.
Methods All consecutive routinely performed AVNRT
ablations from our centre between 1999 and 2007 were
retrospectively analysed.
Results In total, 274 patients were elegible: 150 cryoabla-
tions and 124 RF. Overall procedural success was 96%
(262/274), and equal in both groups, but nine patients were
crossed to another arm. Mean fluoroscopy time was longer
in the group treated with RF (27 ± 22 min vs. cryo 19 ±
15 min; p = 0.002). Mean procedure time was not different
(RF 138 ± 71 min vs. cryo 146 ± 60 min). A permanent
pacemaker was necessary in two RF patients. The ques-
tionnaire revealed a high incidence of late arrhythmia
related symptoms (48%), similar in both groups, with
improved perceived quality of life. The number of redo
procedures for AVNRT over 4.3 ± 2.5-years follow-up was
not statistically different (11% after cryo and 5% after RF).
Conclusions Our data confirm that cryo and RF ablation
with 4-mm tip catheters for AVNRT are equally effective,
even after long-term follow-up.
Keywords Arrhythmias.Atrioventricular block.
Atrioventricular reentrant tachycardia.Catheter ablation.
Cryoablation.Radiofrequency
1 Introduction
Catheter ablation is a successful and widely used
approach for treatment of atrioventricular reentrant
tachycardia (AVNRT). [1, 2] However, there is still debate
about the choice of the most optimal energy. Radio-
frequency (RF) catheter ablation is highly effective but
carries the risk for creating inadvertent atrioventricular
heart block (AVB). [3] Cryoablation (cryo) on the other
hand can be performed very safely due to the possibility of
‘ice mapping’ and ‘cryoadherence’.[ 4]W es h o w e di nt h e
past in a randomised trial that both techniques had the
same acute outcome. [5] However, conflicting data exist
about the recurrence rate with this technique, ranging from
0% to more than 30%. [6–13] In this work, we evaluated
not only the short-term efficacy and safety of RF ablation
and cryothermal ablation of AVNRT in a large series of
patients, but also the long-term outcome.
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All catheter ablations performed at our centre from 24
February 1999 to 19 December 2007 were analysed. In all
procedures, the antiarrhythmic agents were discontinued for
at least five half-lives before the procedure. The ablation
protocols were unchanged during the whole inclusion
period, and were supervised by the same electrophysiolo-
gist. However, the team consisted of several experienced
electrophysiologists, with their own training and preferen-
ces. All procedures were performed under local anaesthesia,
implemented with sedation. The following data were
collected: energy used, acute success, number of applica-
tions, ablation time, fluoroscopy time, procedural time,
acute and late complications and need for redo procedures.
Procedural time was measured from the time of puncturing
the vein until the time of removal of the sheaths from the
groin, including the 30-min waiting period after a success-
ful ablation. The patients included in two previously
published studies were not a part of this retrospective
analysis. [5, 14]
2.1 Ablation procedure
One bipolar catheter, one quadripolar and one decapolar
catheter were inserted to perform a standard electrophysi-
ological study. The catheters were advanced into the heart
and positioned respectively in the right ventricular apex, on
the His bundle and in the coronary sinus. At baseline, the
AH and HV intervals were recorded on the catheter in the
His position, and with programmed electrical stimulation
the presence of dual AV conduction was confirmed, defined
as a AH jump of more than 50 ms. Subsequently,
tachycardia was induced by programmed electrical stimu-
lation or by atrial burst pacing. If sustained, tachycardia
could not be induced, isoprenaline was used. Induction of
AVNRT was performed at least two times before moving
forward to ablation.
Cryoablation Cryoablation was performed by using a
Freezor 3 catheter with a 4-mm tip (Cryocath Technologies,
Montreal, Canada) and a CCT2 CryoConsole (Cryocath
Technologies, Montreal, Canada). At the site of interest, ice
mapping was performed by cooling to −30°C for a
maximum of 60 s. Fluoroscopy was applied until a stable
temperature of −30°C was reached. During the 60 s, atrial
extrastimulus testing was performed. Termination or non-
inducibility of AVNRT or disappearance of an AH-jump
was considered to be an identification of a potentially
successful ablation site. Ablation was subsequently per-
formed using a freezing protocol by cooling to −75°C for a
6-min period to create a permanent lesion. If there was no
clear AH-jump, and AVNRT was difficult to induce at
baseline, prolongation of the anterograde AV refractory
period during atrial extra stimulus testing during ice
mapping was used to identify a target site. The endpoint
was non-inducibility of AVNRT. This was tested after each
application, and if non-inducible, repeated after a 30-min
waiting period.
RF ablation RF catheter ablation was performed using a
4-mm, solid-tip, ablation catheter (Biosense-Webster Inc,
Diamond Bar, CA, USA or an EPT Blazer, Boston Scientific,
San Jose, CA, USA) in a temperature-controlled mode
(maximum temperature 55°C, maximum duration 60 s, max-
imum 40W) with the use ofa Stockert RFgenerator(Biosense-
Webster Inc, Diamond Bar, CA, USA). Ablation of the slow
pathway was guided by a combination of intracardiac electro-
grams and anatomical landmarks. When an optimal balance of
asmallfractionatedAandlargeVsignalswereseen,RFenergy
was appliedstartingat a low energy level.Eachapplicationwas
started with the power set at 10 W and, if AV conduction was
preserved, the power was progressively increased to 40 Wuntil
a maximum of 55°C was reached or junctional rhythm
appeared. Fluoroscopy was used throughout each application.
With both techniques, retrograde conduction was continuously
monitored. The endpoint was non-inducibility of AVNRT. This
was tested after each application, and if non-inducible, repeated
after a 30-min waiting period.
2.2 Follow-up
Before hospital discharge, all patients received a 12-lead
ECG recording and echocardiographic examination. Three
months after the procedure all patients were examined at
the outpatient clinic and asked about recurrent palpitations.
If longstanding palpitations occurred within the follow-up
period, a new 24-h holter monitor was performed or an
effort was made to document the arrhythmia. Patients were
then sent to their referring cardiologist, except when a redo
procedure was necessary. For the purpose of this study, all
patients were again personally approached by the inves-
tigators at the beginning of 2008 with a dedicated
questionnaire, focusing on recurrence, duration and inten-
sity of arrhythmias, antiarrhythmic drug use, cardioversion,
readmission for cardiovascular reasons, for pacemaker
implantation or reablation, also for other arrhythmias. This
questionnaire was also sent to patients included in former
trials as the obtained results were supposed not to be
dependent on acute procedural outcomes [5, 14].
2.3 Statistical analysis
Continuous variables were expressed as mean ± standard
deviation, if normally distributed, or otherwise by median.
56 J Interv Card Electrophysiol (2011) 30:55–61The Students t test or analysis of variance was used when
appropriate. A Chi-square test with Yates correction was
used for categorical data. The level of significance was set
at p < 0.05. For efficacy and complications analysis,
therapy as applied. All statistics were performed using
SPSS (16.0) for Windows (Chicago, Il, USA).
3 Results
3.1 Patient data
Of the 389 consecutive procedures performed at our centre
between 24 February 1999 and 19 December 2007, 81 were
excluded as they were already part of other published
studies [5, 14]. Of the remaining 308 procedures, 16 were
excluded because another arrhythmia was identified during
the study before ablation, and 17 others because of
insufficient data (Fig. 1). Patients in whom AVNRT was
ablated along with another arrhythmia (atrial flutter or atrial
tachycardia) and redo procedures (28, of which 11 with
cryo and 17 with RF) remained included. Eighty-eight
(32%) of 274 patients were male. The overall mean age was
51 ± 17 years, 50 ± 17 in the cryo group vs. 52 ± 17 years
in the RF group (NS).
3.2 Procedure and ablation data
The initial approach was cryoenergy for 150 and RF for
124 ablations (55% vs. 45%). The overall acute success rate
was 95% (262 patients). Of these procedures, 246 were a
first ablation for AVNRT, and 28 were redo procedures.
Only 10/274 patients (3.6%) would fail the ablation (five in
each group had procedural failure), but this implied a cross-
over of eight cryo patients to RF, and one RF to cryo. The
acute failure rate for the final delivered energy modality
was similar for both approaches (cryo 3% vs. RF 4%; NS).
The median number of applications was less in the cryo
group (two vs. six; Table 1). The mean ablation time was
longer in the cryo patients (522 ± 384 s vs. 371 ± 621 s).
The mean fluoroscopy time was shorter in the cryo group
(19 ± 15 min vs. 27 ± 22 min), while the procedure time
was not different (cryo 146 ± 60 min vs. RF 138 ± 71 min).
From the redo procedures, only one (cryo) failed acutely.
3.3 Acute complications
Thirteen patients had temporary AVB (six cryo vs. seven
RF, including one cross-over patient; NS). Two patients had
pericardial effusion needing acute intervention (both in the
RF group). Further, two patients in the RF group received a
permanent PM because of third degree atrioventricular
block with narrow QRS complexes, without recovery
before discharge.
3.4 Long-term follow-up data
After a mean follow-up of 4.3 ± 2.5 years, 20 of the 246
patients (8%) treated for the first time in this series did
undergo a redo ablation. The number of redo AVNRT
procedures divided by the number of first procedures was
not statistically different for both groups (14/132 for cryo vs.
6/114 for RF). During three redo procedures the arrhythmia
proved to be a left-sided concealed accessory pathway.
3.5 Questionnaire
The overall response rate to the questionnaire was 235/389
(61%). Of all patients responding to the questionnaire, 49%
initially underwent cryo and 51% RF ablation (NS). There
was onlyone patient from the cross-overgroup to RF, and she
is included in the RF group. Arrhythmia related symptoms
were reported in 55/115 (47.8%) in the cryo group versus 57/
120 (47.5%) in the RF group (NS). Table 2 displays the
distribution of the arrhythmia pattern and the reported
duration of the arrhythmias as reported in the questionnaire.
Whereas the majority of the patients initially reported
monthly or weekly occurrence of palpitations with a typical
duration of hours, rather than minutes, this changed to no
palpitations or sporadic occurrence, sometimes lasting only
seconds after the procedure (Fig. 2). No differences were
seen between the groups. The perceived quality of life
improved in 102/115 patients (89%) in the cryo vs 106/120
(88%) in the RF group (NS; Fig. 3); 12/115 patients (10%)
in the cryo vs 12/120 (10%) in the RF group (NS) observed
no difference in their quality of life; only 1/115 in the cryo
and 2/120 in the RF group (NS) indicated a deterioration in
perceived quality of life. From the 235 responses, 66 (28%)
Fig. 1 Patient flow chart. At the beginning, study patients were
excluded, resulting in 308 routine procedures. AVNRT, atrioventricular
nodal reentrant tachycardia; RF, radiofrequency
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arrhythmia-related admissions, 19 (54%) were after cryo, 16
(46%) after RF (NS). Two patients were admitted for
elective cardioversion (atrial fibrillation). Five patients
received a device for arrhythmia management. The two late
ICD's were implanted after anterior myocardial infarction
and after development of heart failure in a patient with non-
ischemic cardiomyopathy. Neither conduction disease nor
arrhythmias were recorded in these two patients. The three
late pacemaker indications were sinus node disease (one
from each group), and one second-degree AVB with
symptoms (RF group).
4 Discussion
The major finding of this study is that cryo and RF ablation
for AVNRT are equally effective techniques, also in the
long run. Cryoablation has a better safety profile.
4.1 Procedural efficacy
Both cryo and RF ablation are very successful techniques in
AVNRT ablation. Acute success was very high in previous
studies, and this is confirmed in our observations, which
were also achieved with a 4-mm catheter tip.[5–7]W e
cannot completely explain the relatively high cross-over
rate, but we suspect that physician preference played a role
in this. Use of a 6-mm cryocatheter tip might improve the
success rate, compared to a 4-mm tip, when applying on the
right spot, but also might diminish the potential of ice
mapping, as it yields larger lesions, and therefore might
Table 2 Reported arrhythmia pattern and duration (numbers) before
and after ablation as answered in the questionnaire
Cryoablation (N = 115) RF (N = 120)
Arrhythmia pattern Before After Before After
None 1 63 1 63
Sporadic 9 29 12 33
Monthly 40 15 43 12
Weekly 40 7 35 8
Daily 25 1 29 4
Arrhythmia duration Before After Before After
None 0 77 1 70
Seconds 2 18 3 23
Minutes 30 14 32 17
Hours 72 6 75 9
Days 11 0 9 1
The pattern and duration before and after ablation are different (p <
0.0001); no differences are observed after ablation between the two
treatment modalities
N number; RF radiofrequency ablation
Fig. 2 Reported arrhythmia pattern and duration in the questionnaire
(N = 235) after ablation (percentages) with cryoenergy (left) and RF
(right). There are no differences in both parameters for the two
approaches
Cryoablation RF ablation p value
Nr (final approach) 143 131
Application number (mean ± SD); median 2 ± 22 9 ± 86 <0.001
Ablation time (mean ± SD); s 522 ± 384 317 ± 621 <0.001
Fluoroscopy time (mean ± SD); min 19 ± 15 27 ± 22 <0.002
Procedural time (mean ± SD); min 146 ± 60 138 ± 71 NS
Acute success (nr) 138/143 126/131 NS
Temporary AVB (nr) 6 7 NS
Permanent AVB 0 2 NA
First procedure/Redo 132/11 114/17 NA
Table 1 Procedural data
(analysis including cross-overs)
Analysis taking into account all
patientsastheywerefinallytreated
AVB atrioventricular block; NA
not applicable; nr number; NS
not significant; RF radiofre-
quency; SD standard deviation
58 J Interv Card Electrophysiol (2011) 30:55–61result in false-positive conduction damage so that no
applications are given.[8–13]
The technique of RF ablation is well known:
anatomical and electrical landmarks guide the procedure
aimed to eliminate the slow pathway. The procedure is
associated with some difficulties as the RF catheter tip
moves during ablation due to changes in heart rhythm,
respiratory movements and potential patient movements.
For these reasons and also because of potential
anatomic variations, damage to the fast pathway can
occur in the triangle of Koch which is very small in
comparison to a relatively large RF lesion. The need
for careful imaging during RF ablation, which is not
necessary during cryoablation, explains the shorter
fluoroscopy time in our hands, confirming the data
from other studies. [5, 6, 10]
4.2 Safety
The major potential advantage of cryoablation is its
safety in preserving normal atrioventricular conduction.
The ablation lesions formed by cryomapping probably
always are reversible. Block during mapping at minus
30°C, is a warning that no application should be given
at this site [4]. However, even with short freezes at minus
75°C on the compact AV node or on the His, the
Fig. 3 Percentage of patients indicating an improvement, no
difference or deterioration in their quality of life before and after the
cryoablation (cryo) or radiofrequency (RF) ablation
389 questionnaires sent
235 responded (61%)
66 hospital readmission (28%) 169 no hospital readmission (72%)
35 arrhythmia related admissions
19 after cryo (16.5%) 16 after RF (13.3%)
1 PM for SSS 1 PM for SSS
1 PM for second degree AVB
1 ICD after anterior myocardial infarction with heart failure
1 ICD in non-ischemic cardiomyopathy
Fig. 4 Hospital admissions
according to the questionnaire.
AVB, atrioventricular block;
PM,p a c e m a k e r ;SSS, sick sinus
syndrome; ICD, implantable
cardioverter defibrillator
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after waiting a short time [8]. With both the cryo and RF
approach temporary heart block occurred in a similar
amount. Further, we have seen unexpected temporary
AVB occurring during real cryoablation, after cryomap-
ping without blocking, but have never met inadvertent
persisting heart block after such a procedure [5]. In
contrast, in spite of a well-trained group of electro-
physiologists, we observed two times complete AVB
requiring permanent pacing in the RF group, and detected
one additional late conduction problem after RF.
4.3 Symptoms versus success
Although cryo and RF have very high acute and long-
term success rates, a significant amount of patients still
have some arrhythmia-related complaints as shown by
the questionnaire. Nevertheless, most patients indicate
an improvement in quality of life after the ablation. It
is well known that palpitations after AVNRT ablation
often bear no relationship with the original arrhythmia:
some patient complain of sinus tachycardia, atrial
premature beats, ventricular premature beats or have
an associated arrhythmia [3, 15]. Moreover, after
AVNRT ablation atrial flutter might become present, or
ectopic atrial tachycardia may arise due to the scarring
[3] .I ta l s oh a st ob es a i dw h e ni nterpreting these results
that atrial or ventricular premature beats, which often
initiate AVNRT, are not treated by ablation of the slow
pathway and may continue to provoke symptoms in both
groups. An association with ventricular outflow tachycar-
dia has been described, and is not uncommon [16–18].
Finally, it is known that in the long run, supraventricular
tachycardia is associated with the development of atrial
flutter or fibrillation. This indicates that judging the
success of the AVNRT procedure merely by relying on
symptoms is inefficient and can lead to incorrect
conclusions. [15]
4.4 Late recurrence
Our study suggests that cryo and RF have a similar early
and late failure rate, as reflected by the amount of redo
procedures, even after a mean follow-up of over more than
4 years. When cryo is used on an intelligent way (i.e. with
conventional pacemapping at −30°C), its success rate is
equal to RF ablation in AVNRT (even when using a 4-mm
tip). We always use pacing during cryomapping to prove
that the AH-jump disappears, to see non-inducibility of
AVNRT, or when cryomapping is performed during
tachycardia, to witness termination of the AVNRT. Only
after fulfilling at least one of the aforementioned criteria we
proceed to cryoablation.
4.5 Limitations
The major limitation of this study is its retrospective design.
However, the early results are in line with all former trials
trying to compare cryo with RF in a randomised fashion,
(including our own study) or in a retrospective way [5–13].
Further, the high cross-over rate created a discrepancy
between the number intended to be treated with one approach,
and the number really treated with one or another approach.
However, this minor shift in numbers was taken into account
in the interpretation of the data,s ot h a tt h ef i n a l l yu s e de n e r g y
modality took the benefit and the disadvantage.
The value of the questionnaire can be debated, as no
standardised instrument to measure quality of life was used,
and as no questionnaire was taken before the ablation. [19]
On the other hand, patients indicated a perception of a
better quality of life, indicating that some positive change
occurred in a large majority after the treatment.
4.6 Conclusion
The overall success rate is very high and similar for both
techniques. There is more need for fluoroscopy in the RF
group, but procedures are equal in duration. There was no need
to implant any pacemaker after cryoablation. Our data confirm
thatcryoandRFablationforAVNRTareequallyefficient,even
after long-term follow-up, but still are associated with a high
hospital admission rate during follow-up.
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